J Bone Metab.  2017 Nov;24(4):201-206. 10.11005/jbm.2017.24.4.201.

Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?

• Mansouritorghabeh H
• Rezaieyazdi Z

• KMID: 2397552
• DOI: http://doi.org/10.11005/jbm.2017.24.4.201

Abstract

Bleeding disorders, including hemophilia, can be seen in every ethnic population in the world. Among various bleeding disorders, reduced bone density has been addressed in hemophilia A. In recent years, there has been an increasing interest in addressing osteopenia and osteoporosis in hemophilia A. There is little or no study about the possible susceptibility of other individuals with bleeding disorders to reduced bone density. Questions have been raised about the role of blood coagulation factors in bone mineralization. This review provides new insight and ideas for further survey in the field of bleeding disorders and reduced bone density.

Keyword

Hemophilia A; Hemophilia B; Osteoporosis; Reduced bone density; von Willebrand diseases

MeSH Terms

Blood Coagulation Factors
Bone Density*
Bone Diseases, Metabolic
Calcification, Physiologic
Hemophilia A
Hemophilia B
Hemorrhage*
Osteoporosis
von Willebrand Diseases
Blood Coagulation Factors

Reference

1. Mansouritorghabeh H. Clinical and laboratory approaches to hemophilia A. Iran J Med Sci. 2015; 40:194–205.

2. Mansouritorghabeh H, Rahimi H, Mohades ST, et al. Causes of death among 379 patients with hemophilia: a developing country's report. Clin Appl Thromb Hemost. 2017; DOI: 10.1177/1076029617713873.

3. Mansouritorghabeh H, Rezaieyazdi Z, Saadati N, et al. Reduced bone density in individuals with severe hemophilia B. Int J Rheum Dis. 2009; 12:125–129.

4. Stonebraker JS, Bolton-Maggs PH, Soucie JM, et al. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2010; 16:20–32.

5. Teitel JM, Barnard D, Israels S, et al. Home management of haemophilia. Haemophilia. 2004; 10:118–133.

6. Dorgalaleh A, Dadashizadeh G, Bamedi T. Hemophilia in Iran. Hematology. 2016; 21:300–310.

7. De la Corte-Rodríguez H, Rodríguez-Merchán EC, De la Corte-García H. Rehabilitation of joint surgery in hemophiliacs. In : Rodríguez-Merchán E, editor. Joint surgery in the adult patient with hemophilia. Cham, CH: Springer;2014. p. 89–99.

8. van Galen KPM, Timmer M, de Kleijn P, et al. Clinical joint outcome after joint bleeds in patients with von Willebrand disease is comparable to moderate and severe hemophilia A despite fewer joint bleeds. Blood. 2016; 128:3789.

9. Oldenburg J. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. Blood. 2015; 125:2038–2044.

10. James AH. Von Willebrand: An underdiagnosed disorder: Several forms of the disease exist, and women with excessive reproductive tract bleeding should be tested for it. Contemp OB. GYN. 2017; 62:20–26.

11. Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016; 375:2067–2080.

12. Laffan MA, Lester W, O'Donnell JS, et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol. 2014; 167:453–465.

13. Bullinger M, Von Mackensen S. Quality of life in children and families with bleeding disorders. J Pediatr Hematol Oncol. 2003; 25:Suppl 1. S64–S67.

14. Acharya SS, Coughlin A, Dimichele DM. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost. 2004; 2:248–256.

15. Girolami A, De Marco L, Dal Bo, et al. Rarer quantitative and qualitative abnormalities of coagulation. Clin Haematol. 1985; 14:385–411.

16. Peyvandi F, Bolton-Maggs PH, Batorova A, et al. Rare bleeding disorders. Haemophilia. 2012; 18:Suppl 4. 148–153.

17. Peyvandi F, Spreafico M. National and international registries of rare bleeding disorders. Blood Transfus. 2008; 6:Suppl 2. S45–S48.

18. Fischer K, de Kleijn P, Negrier C, et al. The association of haemophilic arthropathy with health-related quality of life: a post hoc analysis. Haemophilia. 2016; 22:833–840.

19. Howell C, Scott K, Patel DR. Sports participation recommendations for patients with bleeding disorders. Transl Pediatr. 2017; 6:174–180.

20. Salomon T, Chaves DG, Brener S, et al. Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population. Haemophilia. 2017; 23:42–49.

21. Mansouritorghabeh H, Rezaieyazdi Z. Bleeding disorders and reduced bone density. Rheumatol Int. 2011; 31:283–287.

22. Paschou SA, Anagnostis P, Karras S, et al. Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis. Osteoporos Int. 2014; 25:2399–2407.

23. Konkle BA, Huston H, Nakaya Fletcher S, Hemophilia A. Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews(R). Seattle, WA: University of Washington, Seattle;1993-2017.

24. Miljić P, Bodrožić J, Tulic G, et al. Femoral neck fracture in hemophilia patients: a single center experience. Haemophilia. 2016; 22:88.

25. Gallacher SJ, Deighan C, Wallace AM, et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Q J Med. 1994; 87:181–186.

26. Wallny TA, Scholz DT, Oldenburg J, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007; 13:79–84.

27. Nair AP, Jijina F, Ghosh K, et al. Osteoporosis in young haemophiliacs from western India. Am J Hematol. 2007; 82:453–457.

28. Barnes C, Wong P, Egan B, et al. Reduced bone density among children with severe hemophilia. Pediatrics. 2004; 114:e177–e181.

29. Abdelrazik N, Reda M, El-Ziny M, et al. Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology. 2007; 12:431–437.

30. Gerstner G, Damiano ML, Tom A, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009; 15:559–565.

31. Iorio A, Fabbriciani G, Marcucci M, et al. Bone mineral density in haemophilia patients. A meta-analysis. Thromb Haemost. 2010; 103:596–603.

32. Tlacuilo-Parra A, Morales-Zambrano R, Tostado-Rabago N, et al. Inactivity is a risk factor for low bone mineral density among haemophilic children. Br J Haematol. 2008; 140:562–567.

33. Mansouritorghabeh H, Rezaieyazdi Z, Badiei Z. Are individuals with severe haemophilia A prone to reduced bone density? Rheumatol Int. 2008; 28:1079–1083.

34. Lanyon LE. Using functional loading to influence bone mass and architecture: objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process in bone. Bone. 1996; 18:37s–43s.

35. Heijnen L, Mauser-Bunschoten EP, Roosendaal G. Participation in sports by Dutch persons with haemophilia. Haemophilia. 2000; 6:537–546.

36. Booth J, Lu M, Gallo D, et al. Increased risk of adverse bone health outcomes in people with bleeding disorders. Blood. 2016; 128:250.

37. Larson EA, Taylor JA. Factor IX-deficient mice have decreased skeletal health. Blood. 2016; 128:559.

38. Khawaji M, Akesson K, Berntorp E. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia. 2009; 15:261–266.

39. Boban A, Zupancic Salek S, Kastelan D, et al. Quantitative ultrasound and dual energy X-ray absorptiometry in the assessment of osteoporosis in patients with haemophilia. Haemophilia. 2014; 20:e420–e422.

40. Kempton CL, Antun A, Antoniucci DM, et al. Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia. 2014; 20:121–128.

41. Lee A, Boyd SK, Kline G, et al. Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia. Blood. 2015; 125:2160–2163.

42. Roushan N, Meysamie A, Managhchi M, et al. Bone mineral density in hemophilia patients. Indian J Hematol Blood Transfus. 2014; 30:351–355.

43. Wells AJ, McLaughlin P, Simmonds JV, et al. A case-control study assessing bone mineral density in severe haemophilia A in the UK. Haemophilia. 2015; 21:109–115.

44. Anagnostis P, Karras S, Paschou SA, et al. Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk. Blood Coagul Fibrinolysis. 2015; 26:599–603.

45. Mansouritorghabeh H, Rezaieyazdi Z, Rezai J. Reduced bone density in individuals with combined factor V and VIII deficiency. Haemophilia. 2007; 13:340–343.

46. Oh YH, Moon JH, Cho B. Association between hemoglobin level and bone mineral density in Korean adults. J Bone Metab. 2017; 24:161–173.

47. Peyvandi F, Duga S, Akhavan S, et al. Rare coagulation deficiencies. Haemophilia. 2002; 8:308–321.

48. Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia. 2008; 14:1151–1158.

49. Peyvandi F, Kaufman RJ, Seligsohn U, et al. Rare bleeding disorders. Haemophilia. 2006; 12:Suppl 3. 137–142.

50. Mansouritorghabeh H, Manavifar L, Mobalegh A, et al. Haemorrhagic manifestations and prevalence of factor V deficiency in north-eastern Iran. Haemophilia. 2010; 16:376–380.

51. Lak M, Sharifian R, Peyvandi F, et al. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol. 1998; 103:1067–1069.

52. Mansouritorghabeh H, Badiei Z, Noori F. Clinical pictures and prevalence of factor VII deficiency in Northeastern of Iran. Haemophilia. 2008; 14:157–159.

53. Brown DL, Kouides PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia. 2008; 14:1176–1182.

54. Zucker M, Seligsohn U, Salomon O, et al. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost. 2014; 12:1121–1130.

55. Baldua V, Kadam P, Castellino N, et al. Factor XII deficiency. RGUHS J Med Sci. 2017; 7:81–82.

56. Dorgalaleh A, Naderi M, Hosseini MS, et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost. 2015; 41:323–329.

57. Mansouritorghabeh H, Shirdel A. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial. J Thromb Haemost. 2016; 14:336–339.